DATA ON PRE-IMPLANTATION GENETIC TESTING IN PAST THREE YEARS

NOTICE PAPER NO. 1111
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR THE SITTING OF PARLIAMENT ON 04 AUGUST 2026

Name and Constituency of Member of Parliament
Ms Valerie Lee
MP for Pasir Ris-Changi GRC

Question No. 1758
To ask the Coordinating Minister for Social Policies and Minister for Health (a) what are the annual numbers, indications, and success rates of pre-implantation genetic testing in Singapore in the past three years; and (b) whether the Government will consider enhancing financial subsidies or MediSave coverage for eligible couples using such testing, given rising maternal age, to improve access and support fertility outcomes and Singapore’s total fertility rate.

Answer

1        Pre-implantation Genetic Testing for Aneuploidy (PGT-A) is currently being carried out as a pilot project at public Assisted Reproduction centres. Under the pilot, the test is subsidized for women undergoing In-Vitro Fertilisation and meet the eligibility criteria, namely, aged 35 years and above, who had experienced two or more recurrent implantation failures, suffered two or more pregnancy losses, or had two or more embryos or fetuses with chromosomal abnormalities.  

2        As of 31 January 2026, 303 women underwent PGT-A. These led to 119 pregnancies with 92 live births.  The rate of pregnancy is therefore higher with a PGT-A test.  MOH is reviewing the pilot scheme.